BRITTNEY ULNESS: Open Payments
NPI 1942782818 · SHEBOYGAN, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,451 in 187 payments from 20 companies in 2025. Trend: 2023 $4,661 · 2024 $4,170 · 2025 $3,451
Food & beverage: $3,451
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 29 | $598 |
| Regeneron Healthcare Solutions, Inc. | 14 | $344 |
| Janssen Biotech, Inc. | 19 | $324 |
| Novartis Pharmaceuticals Corporation | 18 | $278 |
| LEO Pharma Inc. | 10 | $273 |
| E.R. Squibb & Sons, L.L.C. | 21 | $258 |
| ABBVIE INC. | 13 | $237 |
| Lilly USA, LLC | 13 | $216 |
| GENZYME CORPORATION | 10 | $166 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $160 |
Products named: Bimzelx, DUPIXENT, TREMFYA, Sotyktu, TALTZ, SKYRIZI, COSENTYX, OTEZLA.
Industry payments across WI — which companies pay providers there.
